Barlow Wealth Partners Inc. Boosts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)
by Renee Jackson · The Cerbat GemBarlow Wealth Partners Inc. raised its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 29.3% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 47,460 shares of the healthcare conglomerate’s stock after buying an additional 10,756 shares during the period. UnitedHealth Group accounts for about 3.2% of Barlow Wealth Partners Inc.’s investment portfolio, making the stock its 8th biggest position. Barlow Wealth Partners Inc.’s holdings in UnitedHealth Group were worth $24,857,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of UNH. NewSquare Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. Hurley Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter worth $28,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at $30,000. Finally, Promus Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at $32,000. Institutional investors and hedge funds own 87.86% of the company’s stock.
Insider Activity
In other UnitedHealth Group news, CEO Stephen J. Hemsley purchased 86,700 shares of the business’s stock in a transaction on Friday, May 16th. The stock was acquired at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the acquisition, the chief executive officer directly owned 679,493 shares of the company’s stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Kristen Gil acquired 3,700 shares of the company’s stock in a transaction dated Thursday, May 15th. The stock was bought at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the transaction, the director directly owned 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 109,408 shares of company stock valued at $31,607,768. Corporate insiders own 0.28% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research analysts have issued reports on UNH shares. Morgan Stanley cut their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 14th. Argus cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, April 21st. Royal Bank Of Canada cut their price target on UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating on the stock in a research note on Friday, May 16th. KeyCorp dropped their price objective on UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating for the company in a report on Monday, June 2nd. Finally, Truist Financial restated a “buy” rating and set a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $415.57.
Read Our Latest Research Report on UNH
UnitedHealth Group Stock Performance
UNH opened at $307.69 on Thursday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The company has a market capitalization of $279.12 billion, a price-to-earnings ratio of 12.88, a P/E/G ratio of 1.55 and a beta of 0.45. The business’s 50-day moving average price is $329.50 and its two-hundred day moving average price is $450.21. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the business earned $6.91 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a $2.21 dividend. The ex-dividend date was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.87%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s payout ratio is currently 37.02%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- Dividend Capture Strategy: What You Need to Know
- Why Hims & Hers Is a Buy Below $35 After Its 16% Pullback
- How to Find Undervalued Stocks
- Nike’s Stock Just Got an Upgrade: Is a Real Comeback Brewing?
- Pros And Cons Of Monthly Dividend Stocks
- Rocket Lab: Latest Catalysts Bolster the Bull Case
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).